Bastide Le Confort Médical (BLC) H2 23/24 TU earnings summary

Executive summary

• Annual revenue reached €529.7 million, up 8.2% year-over-year, surpassing the €520 million target.

• Organic growth accelerated to 9.5% in Q4, with full-year organic growth at 7.4%.

• Profitability target of 8.4% recurring operating margin confirmed for 2023-2024.

Financial highlights

• Q4 revenue was €134.5 million, up 10.1% compared to Q4 last year.

• International business contributed 16.6% of total revenue.

• Companies acquired in the last year added €0.7 million to Q4 revenue.

Outlook and guidance

• Revenue target for 2024-2025 set at over €560 million, mainly driven by home healthcare services.

• Continued focus on debt reduction through divestment of low-growth assets.